Intellectual property and COVID-19 medicines: why a WTO waiver may not be enough




Bonadio Enrico, Cadillo Chandler Dhanay M.

PublisherThe Conversation Trust (UK) Limited

2021

24.2.2021

https://theconversation.com/intellectual-property-and-covid-19-medicines-why-a-wto-waiver-may-not-be-enough-155920(external)




Last updated on 2024-26-11 at 20:01